mda-mb-468 glutathione content Using a novel panel of
Using a novel panel of drug resistant triple negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers ScienceDirect Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells Scientific Reports Lobetyolin inhibited the proliferation of MDA MB 231 and MDA MB 468 Download Scientific Diagram MDA MB 468 Xenograft Model Altogen Labs
Pay in 4 interest-free payments of $6.79 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21


